Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryohei Sumitani

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Hematology|April 11, 2023
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitorsEmiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, et al.
Research Square|July 18, 2025
Development of a rapid and novel diagnostic technique for cardiac amyloidosis using Raman spectroscopyMizuki Yoshimoto, Shin-Ichiro Yanagiya, Hiroki Takanari, et al.
Blood Advances|September 21, 2022
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinaseTakeshi Harada, Hiroto Ohguchi, Asuka Oda, et al.
BMJ Supportive & Palliative Care|May 9, 2022
Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strengthShin Kondo, Tatsuro Inoue, Takashi Saito, et al.
Cancer Science|November 18, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interactionYusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi, et al.
Antioxidants (Basel, Switzerland)|January 21, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin, et al.
Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.
Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.
Cancers|April 15, 2020
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of FebuxostatMohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi, et al.
International Journal of Hematology|January 21, 2024
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitorsKimiko Sogabe, Shingen Nakamura, Yoshiki Higa, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Hematology|April 11, 2023
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitorsEmiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, et al.
Research Square|July 18, 2025
Development of a rapid and novel diagnostic technique for cardiac amyloidosis using Raman spectroscopyMizuki Yoshimoto, Shin-Ichiro Yanagiya, Hiroki Takanari, et al.
Blood Advances|September 21, 2022
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinaseTakeshi Harada, Hiroto Ohguchi, Asuka Oda, et al.
BMJ Supportive & Palliative Care|May 9, 2022
Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strengthShin Kondo, Tatsuro Inoue, Takashi Saito, et al.
Cancer Science|November 18, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interactionYusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi, et al.
Antioxidants (Basel, Switzerland)|January 21, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin, et al.
Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.
Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.
Cancers|April 15, 2020
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of FebuxostatMohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi, et al.
International Journal of Hematology|January 21, 2024
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitorsKimiko Sogabe, Shingen Nakamura, Yoshiki Higa, et al.
Pageof 3